This is a prescription medicine. A prescription is required from your veterinarian before we can supply this product. Please ensure that you have read the "How to Order" page before ordering this item.
All of our products are APVMA or TGA approved and identical to those used by your veterinarian. Please call or email us if you have any queries about any of the products on our site.
|Drug Name and Strength||Cloprostenol 250mcg/ml|
|Indication||Cattle, therapeutic use. A single intramuscular dose of Estrumate is likely to be highly effective in the following clinical conditions of the cow. Suboestrus (or undetected oestrus). This condition occurs in heavy yielding cows, usually at peak lactation, which have normal ovarian cyclicity but in which behavioural manifestation of oestrus is either very mild, transient or absent. Such animals can be treated with Estrumate following diagnosis of a corpus luteum by rectal palpation and then closely observed for oestrus. Those showing heat should be inseminated. Some animals may have been treated during the refractory period of the cycle and therefore will not respond. Animals not showing heat should receive a further single injection eleven days after the first and be inseminated 72 and 96 hours later. Termination of normal but unwanted pregnancies. Pregnancy can be terminated from one week after conception until the 150th day of gestation. Before 100 days gestation, abortion can be induced rapidly and efficiently, but between 100 and 150 days of gestation results are less reliable, probably because a proportion of cattle may become progressively less dependent upon the corpus luteum for the maintenance of pregnancy. Abortion should not be induced after day 150 of gestation. Treated animals should be kept under supervision until expulsion of the foetus and the placental membranes is complete, as an occasional animal may develop metritis following abortion. Most cows will abort in three to five days; if an animal has not aborted by the eighth day, a second injection should be given. Termination of abnormal pregnancy; removal of mummified foetus. Death of the conceptus may be followed by its dehydration and degeneration. Induction of luteolysis at any stage of pregnancy will result in the expulsion of this mummified foetus from the uterus into the vagina. Manual removal from the vagina may be necessary. Normal cyclical activity should then follow. Hydrops of the foetal membranes. Pathological accumulation of placental fluids, hydramnios or hydrallantois, can cause severe physiological complications and death. Surgical drainage is not usually successful in alleviating the condition. A single dose of Estrumate may be used to induce parturition in such cases; success has been achieved as early as the sixth month of pregnancy. Chronic endometritis (pyometra). Damage to the reproductive tract at calving, or postpartum retention of the placenta, frequently lead to infection and inflammation of the uterus. Acute or subacute endometritis occurring shortly after parturition may require both local and systemic antibiotic treatment and this often results in resolution of the condition. However, under certain circumstances, the endometritis may progress until, at a few weeks postpartum, the uterus is very swollen, of a soft ‘doughy’ consistency, and full of purulent discharge. This is characterised by a lack of cyclical oestrus behaviour and the presence of a persistent corpus luteum. This condition can be successfully treated by induction of luteal regression. Where necessary, treatment may be repeated at ten to 14 day intervals. Induction of parturition. Induction of parturition should take place as close to the predicted calving date as possible and not more than ten days before. Induction should not be attempted before day 270 of gestation measured from the confirmed day of conception. All treated animals must receive adequate supervision. In common with all other methods of shortening the gestation period, a higher than usual incidence of retention of the foetal membranes is to be expected. It is now recognised that there may be a reduced survival rate in calves born as a result of early induction. Any increased mortality is due to lack of viability as a result of prematurity rather than any effect from the prostaglandins. Ovarian luteal cysts. Where cystic ovaries associated with persistent luteal tissue and absence of oestrus are diagnosed, Estrumate has proved effective in correcting the condition and bringing about a return of cycling. Accurate diagnosis is essential if completely satisfactory results are to be achieved.Cattle, controlled breeding programs. The luteolytic activity of Estrumate can be harnessed to control the breeding pattern of cattle. A variety of treatment regimens exists from which it is possible to choose the most appropriate for the characteristics and objectives of each particular herd. Individuals or groups of animals can be controlled, as required. Estrumate can be used to complement oestrus detection input, or animals may be bred ‘on schedule’ during critical times of the breeding season, without reference to oestrus detection.Dairy herd. Control of oestrus in individual animals. This gives better control of the calving index by allowing artificial insemination (AI) without oestrus detection. The number of cows culled as barren is consequently reduced. Synchronisation of oestrus in groups of cows. This promotes management of the herd in groups of suitable size for feeding, AI and ‘drying off’. The chances of maintaining a strictly seasonal calving herd are improved and the number of barren cows at the end of the breeding program is reduced. Use of AI in dairy heifers. Estrumate facilitates AI, which in turn, allows the speeding up of the breeding program, the use of a bull known to produce few dystocia problems and better control of heifer management, and steaming up prior to calving.Beef herd. Facilitation of the use of AI. This improves the progeny through the use of genetically superior bulls. The problems of oestrus detection are avoided and the labour involved in carrying out an AI program is reduced by allowing groups of cattle to be presented instead of single animals. Better management at conception and calving. The calving pattern is altered, resulting in greater average age and weight of calves at weaning. The peak calving period can be forecast more accurately in relation to other events in the farm calendar and there is an improved potential for ‘flushing’ the cows prior to AI.Horses. Estrumate as a potent luteolytic agent causes regression of the corpus luteum in mares in a variety of circumstances. Luteolysis is usually followed by oestrus, appearing two to four days after treatment, with ovulation during the induced oestrus. This sequence of events is seen, for example, in mares treated with Estrumate during dioestrus (the progestational) phase of the oestrus cycle, but it should be noted that there is a refractory period of four to five days after ovulation when mares are not responsive to the luteolytic action of prostaglandins.Estrumate has a wide margin of safety and has no deleterious effect on foals conceived and born as a result of mares being covered at the induced oestrus. This property of shortening the life span of the corpus luteum makes Estrumate of clinical value in the following. Induction of luteolysis following early foetal death and resorption. About 8 to 10% of all mares which conceive lose the conceptus during the first 100 days of pregnancy. Persistence of luteal function in the ovary precludes an early return of oestrus. Treatment before day 45 is recommended. After that time no response may be obtained due to the presence of circulating pregnant mare serum gonadotrophin (PMSG). Termination of pseudopregnancy. Some mares covered at normal oestrus and subsequently found to be empty (but not having lost or resorbed a conceptus) display clinical signs of pregnancy. These animals are said to be ‘pseudopregnant’. Treatment of lactation anoestrus. Failure of lactating mares to cycle again for several months after exhibiting an early ‘foal heat’ can be avoided in most cases. Some variability does, however, occur. Barren and maiden mares. Some of these animals will be found on examination to have a functional corpus luteum and are either suffering from abnormal persistence of luteal function or are simply failing to exhibit normal oestrus behaviour (‘silent heat’) while ovarian cyclicity continues. Synchronisation of oestrus. Under some circumstances this may be a desirable objective in stud management. Treatment during dioestrus usually induces oestrus after two to four days, with ovulation occurring eight to twelve days after treatment. Nomination of the time of service. Mares may be brought into oestrus at will, simply as an aid to successful and economic management of stallions during the breeding season.|
|Contraindications||Cattle. Administration to pregnant animals if the calf is not to be aborted; luteolysis at some stages of gestation will cause foetal loss. Intravenous injection. Horses. Administration to mares suffering from acute or subacute disorders of the gastrointestinal tract, acute or subacute respiratory disease. (In some species of animals, dosing with prostaglandins can result in acute respiratory distress.) Administration to pregnant mares; luteolysis at some stages in gestation will cause foetal loss.|
|Actions||A luteolytic agent for clinical use in the bovine and equine oetrous cycles. Estrumate is a synthetic prostaglandin analogue structurally related to prostaglandin F2α (PGF2α). It is a potent luteolytic agent, causing functional and morphological regression of the corpus luteum (luteolysis). Luteolysis is usually followed by return of oestrus two to four days after treatment, and normal ovulation.|
|Precautions||Estrumate can be absorbed through the skin and therefore, care should be taken when handling the product, especially by women of childbearing age and by asthmatics. Accidental spillage on the skin should be washed off immediately with water. Prostaglandins of the F2α type may cause bronchospasm in humans, although the possible incidence of this effect with Estrumate is not known.First Aid Should respiratory embarrassment result from accidental inhalation or injection, a rapid acting bronchodilator, e.g. isoprenaline or salbutamol by inhalation, is indicated.|
|Dosage and Administration||Cattle. Single or repeat doses of 2 mL (cloprostenol 500 microgram) by intramuscular injection. Horses. A single intramuscular injection of 0.5 to 1 mL for animals up to 400 kg bodyweight; over 400 kg bodyweight: 1 to 2 mL.|
|Storage||Store below 25°C (air conditioning). Protect from light.|
|MSDS (external link)||Estrumate 20ml MSDS|
|Label (external link)||Estrumate 20ml Label|
|Manufacturer||MSD Animal Health|